Hin Sang Group (International) Holding Co. Ltd.

Equities

6893

KYG4590V1023

Pharmaceuticals

Market Closed - Hong Kong S.E. 04:08:16 2024-04-24 am EDT 5-day change 1st Jan Change
0.3 HKD -6.25% Intraday chart for Hin Sang Group (International) Holding Co. Ltd. -9.09% -10.45%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Hin Sang Group (International) Holding Co. Ltd. Announces Change of Company Secretary, Effective 19 February 2024 CI
Hin Sang Group Narrows Fiscal H1 Loss MT
Hin Sang Group (International) Holding Co. Ltd. Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Hin Sang's Loss to Narrow in Fiscal H1 MT
Hin Sang Group (International) Holding Co. Ltd. Provides Earnings Guidance for the Six Months Ended 30 September 2023 CI
Hin Sang Group's Fiscal Year 2023 Loss Widens Four Times MT
Hin Sang Group (International) Holding Co. Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Hin Sang Excepts Loss to Widen for Fiscal Year 2023 MT
Hin Sang Group (International) Holding Co. Ltd. Provides Earnings Guidance for the Financial Year Ended 31 March 2023 CI
Hin Sang Group’s April-Sept Loss Widens as Revenue Falls 4% MT
Hin Sang Group (International) Holding Co. Ltd. Reports Earnings Results for the Half Year Ended September 30, 2022 CI
Hin Sang Group (International) Holding Co. Ltd. Auditor Raises 'Going Concern' Doubt CI
Hin Sang Group (International) Holding Co. Ltd. Announces Management Changes, Effective 1 July 2022 CI
Hin Sang Group Logs $1.7 Million Net Loss in FY22 MT
Hin Sang Group (International) Holding Co. Ltd. Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Hin Sang Expects Decrease in FY22 Net Loss; Shares Climb 3% MT
Hin Sang Group (International) Holding Co. Ltd. Provides Earnings Guidance for the Year Ended 31 March 2022 CI
Hin Sang Group Unit Ties Up with Hongli Homologous Biotechnology to Open Chain Stores in China MT
Hin Sang Group (International) Holding Co. Ltd. Reports Earnings Results for the Half Year Ended September 30, 2021 CI
Hin Sang Group (International) Holding Co. Ltd. Appoint Tian Shanshan as A Non-Executive Director with Effect from 1 December 2021 CI
Hin Sang Group (International) Holding Co. Ltd. Provides Earnings Guidance for the Six Months Ended September 30, 2021 CI
Hin Sang Group (International) Holding Co. Ltd. Announces the Retirement of Yuen Chi Ping as Non-Executive Director CI
Hin Sang Group (International) Holding Co. Ltd. Announces Change of Company Secretary CI
Hin Sang Group (International) Holding Co. Ltd. Announces Unaudited Consolidated Earnings Results for the Year Ended 31 March 2021 CI
Hin Sang International : Group FY21 Loss Swells, Revenue Falls MT
Chart Hin Sang Group (International) Holding Co. Ltd.
More charts
Hin Sang Group (International) Holding Co. Ltd. is an investment holding company principally engaged in development, marketing and sales of care products, healthcare products and household products under various brands. The Company operates its business through three segments. The Product Development segment is engaged in the sales of products developed by the Company under own brands. The Brand Development and Management segment is engaged in the sales and distribution of products with exclusive distribution rights. The Trading of Goods segment is engaged in the sales and distribution of products purchased from authorized dealers, independent traders, manufacturers and parallel importers.
More about the company
  1. Stock Market
  2. Equities
  3. 6893 Stock
  4. News Hin Sang Group (International) Holding Co. Ltd.
  5. Hin Sang Expects Decrease in FY22 Net Loss; Shares Climb 3%